Methodological approaches to evaluate the impact of FDA drug safety communications.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 25968811)

Published in Drug Saf on June 01, 2015

Authors

Aaron S Kesselheim1, Eric G Campbell, Sebastian Schneeweiss, Paula Rausch, Brian M Lappin, Esther H Zhou, John D Seeger, John S Brownstein, Steven Woloshin, Lisa M Schwartz, Timothy Toomey, Gerald J Dal Pan, Jerry Avorn

Author Affiliations

1: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Suite 3030, 1620 Tremont Street, Boston, MA, 02120, USA, akesselheim@partners.org.

Articles by these authors

The global distribution and burden of dengue. Nature (2013) 27.92

Electronic health records in ambulatory care--a national survey of physicians. N Engl J Med (2008) 17.18

Use of electronic health records in U.S. hospitals. N Engl J Med (2009) 14.36

Variable selection for propensity score models. Am J Epidemiol (2006) 10.68

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66

A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77

Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44

Enthusiasm for cancer screening in the United States. JAMA (2004) 8.22

Emerging fungal threats to animal, plant and ecosystem health. Nature (2012) 8.20

When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ (2013) 8.12

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31

Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19

Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med (2008) 7.05

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57

Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance. Am J Prev Med (2011) 6.45

HealthMap: global infectious disease monitoring through automated classification and visualization of Internet media reports. J Am Med Inform Assoc (2007) 6.33

Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain (2004) 6.32

A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47

Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis (2012) 5.29

Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol (2003) 4.95

Social and news media enable estimation of epidemiological patterns early in the 2010 Haitian cholera outbreak. Am J Trop Med Hyg (2012) 4.74

Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 4.70

Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med (2004) 4.68

Too Little? Too Much? Primary care physicians' views on US health care: a brief report. Arch Intern Med (2011) 4.53

Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med (2011) 4.53

Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51

The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47

New FDA breakthrough-drug category--implications for patients. N Engl J Med (2014) 4.30

Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst (2002) 4.16

Lost in transmission--FDA drug information that never reaches clinicians. N Engl J Med (2009) 4.12

Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial. JAMA (2007) 4.11

Physicians' perceptions, preparedness for reporting, and experiences related to impaired and incompetent colleagues. JAMA (2010) 3.98

A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98

Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis (2013) 3.90

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85

Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82

The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med (2006) 3.64

Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med (2014) 3.62

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA (2003) 3.57

Early detection of disease outbreaks using the Internet. CMAJ (2009) 3.54

Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54

Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ (2010) 3.46

Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med (2009) 3.44

Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ (2013) 3.43

Press releases: translating research into news. JAMA (2002) 3.41

Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med (2011) 3.38

GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med (2013) 3.37

The quality of pharmacologic care for vulnerable older patients. Ann Intern Med (2004) 3.34

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33

Digital epidemiology. PLoS Comput Biol (2012) 3.33

Global capacity for emerging infectious disease detection. Proc Natl Acad Sci U S A (2010) 3.30

Conflicts of interest in cardiovascular clinical practice guidelines. Arch Intern Med (2011) 3.29

Residents report on adverse events and their causes. Arch Intern Med (2005) 3.29

The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27

Rethinking the use of physicians as hired expert lecturers. Ann Intern Med (2014) 3.22

Use of unstructured event-based reports for global infectious disease surveillance. Emerg Infect Dis (2009) 3.20

Drug-review deadlines and safety problems. N Engl J Med (2008) 3.16

Using web search query data to monitor dengue epidemics: a new model for neglected tropical disease surveillance. PLoS Negl Trop Dis (2011) 3.14

Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis (2008) 3.09

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09

Balancing innovation, access, and profits--market exclusivity for biologics. N Engl J Med (2009) 3.08

Responses of medical schools to institutional conflicts of interest. JAMA (2008) 3.07

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA (2011) 3.02

Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med (2012) 3.01

Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01

Electronic health records in small physician practices: availability, use, and perceived benefits. J Am Med Inform Assoc (2011) 2.98

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98

Outcomes of neonates undergoing extracorporeal membrane oxygenation support using centrifugal versus roller blood pumps. Ann Thorac Surg (2012) 2.97

Risk charts: putting cancer in context. J Natl Cancer Inst (2002) 2.96

University-based science and biotechnology products: defining the boundaries of intellectual property. JAMA (2005) 2.95

Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91

Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85

Promoting healthy skepticism in the news: helping journalists get it right. J Natl Cancer Inst (2009) 2.82

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82